Pacific Biosciences of California, Inc. (PACB)
NASDAQ: PACB · Real-Time Price · USD
1.280
-0.070 (-5.19%)
At close: Aug 24, 2026, 4:00 PM EDT
1.320
+0.040 (3.13%)
Pre-market: Aug 25, 2026, 4:30 AM EDT
PACB Revenue
Pacific Biosciences of California had revenue of $39.01M in the quarter ending June 30, 2026, a decrease of -1.91%. This brings the company's revenue in the last twelve months to $159.27M, up 2.02% year-over-year. In the year 2025, Pacific Biosciences of California had annual revenue of $160.01M with 3.89% growth.
Revenue (ttm)
$159.27M
Revenue Growth
+2.02%
P/S Ratio
2.50
Revenue / Employee
$328,394
Employees
485
Market Cap
397.86M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 160.01M | 5.99M | 3.89% |
| Dec 31, 2024 | 154.01M | -46.51M | -23.19% |
| Dec 31, 2023 | 200.52M | 72.22M | 56.29% |
| Dec 31, 2022 | 128.30M | -2.21M | -1.69% |
| Dec 31, 2021 | 130.51M | 51.62M | 65.43% |
| Dec 31, 2020 | 78.89M | -12.00M | -13.20% |
| Dec 31, 2019 | 90.89M | 12.27M | 15.60% |
| Dec 31, 2018 | 78.63M | -14.84M | -15.88% |
| Dec 31, 2017 | 93.47M | 2.75M | 3.04% |
| Dec 31, 2016 | 90.71M | -2.07M | -2.23% |
| Dec 31, 2015 | 92.78M | 32.19M | 53.12% |
| Dec 31, 2014 | 60.59M | 32.41M | 115.02% |
| Dec 31, 2013 | 28.18M | 2.20M | 8.46% |
| Dec 31, 2012 | 25.98M | -7.88M | -23.27% |
| Dec 31, 2011 | 33.86M | 32.19M | 1,922.88% |
| Dec 31, 2010 | 1.67M | 1.54M | 1,140.00% |
| Dec 31, 2009 | 135.00K | -766.00K | -85.02% |
| Dec 31, 2008 | 901.00K | -1.26M | -58.34% |
| Dec 31, 2007 | 2.16M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Orthofix Medical | 833.19M |
| Tactile Systems Technology | 350.31M |
| Viemed Healthcare | 301.61M |
| NeuroPace | 106.99M |
| Sight Sciences | 83.38M |
| Electromed | 71.75M |
| 908 Devices | 60.84M |
| Senseonics Holdings | 48.55M |
PACB News
- 13 days ago - Pacific Biosciences of California Transcript: Canaccord Genuity's 46th Annual Growth Conference - Transcripts
- 19 days ago - Pacific Biosciences of California Earnings Call Transcript: Q2 2026 - Transcripts
- 19 days ago - Pacific Biosciences of California Slides: Q2 2026 - Filings
- 19 days ago - Pacific Biosciences of California Earnings release: Q2 2026 - Filings
- 19 days ago - Pacific Biosciences of California Quarterly report: Q2 2026 - Filings
- 19 days ago - PacBio Appoints Mark Van Oene as President and Chief Executive Officer - GlobeNewsWire
- 19 days ago - PacBio Announces Second Quarter 2026 Financial Results - GlobeNewsWire
- 19 days ago - PacBio Announces Faster Runs, Up to 50% More HiFi Data, and New Compliance Controls for the Vega system - GlobeNewsWire